File Download
 
 
Patent History
 
Supplementary

Granted Patent: Diazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use
  • Basic View
  • Metadata View
  • XML View
TitleDiazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use
 
Granted PatentUS 7468434
 
Granted Date2008-12-23
 
Priority Date2005-12-21 US 11/313513
2004-12-22 US 11/638100P
 
InventorsVanhoutte, Paul Michel Geo
Che, Chi Ming
So, Kwok Fai
Sham, Hiu Tung Iona
 
Issue Date2008
 
CitationUS Patent 7468434. Washington, DC: US Patent and Trademark Office (USPTO), 2008 [How to Cite?]
 
AbstractThis Invention Provides A Method For Treating An Eye Disease In A Patient Comprising: Providing A Photosensitive Prodrug That Releases Upon Exposure To Light An Active Ingredient To Treat The Eye Disease; Administering The Prodrug In A Pharmaceutically Accepted Vehicle To The Subject, And Exposing The Eye Of The Subject To An External Light Source To Cause The Prodrug To Release The Active Ingredient. This Invention Also Provides A Composition For The Treatment Of Glaucoma, Comprising A Compound Containing A Lithium Ion-Chelated In A Crown Ether- Or Aza-Crown Ether-Containing Chromene Or Diazene Derivative And A Pharmaceutically Acceptable Carrier.
 
DC FieldValue
dc.contributor.inventorVanhoutte, Paul Michel Geo
 
dc.contributor.inventorChe, Chi Ming
 
dc.contributor.inventorSo, Kwok Fai
 
dc.contributor.inventorSham, Hiu Tung Iona
 
dc.date.accessioned2011-10-19T06:25:03Z
 
patents.date.application2005-12-21
 
dc.date.available2011-10-19T06:25:03Z
 
patents.date.granted2008-12-23
 
dc.date.issued2008
 
patents.date.priority2005-12-21 US 11/313513
 
patents.date.priority2004-12-22 US 11/638100P
 
patents.date.publication2007-12-27
 
dc.description.abstractThis Invention Provides A Method For Treating An Eye Disease In A Patient Comprising: Providing A Photosensitive Prodrug That Releases Upon Exposure To Light An Active Ingredient To Treat The Eye Disease; Administering The Prodrug In A Pharmaceutically Accepted Vehicle To The Subject, And Exposing The Eye Of The Subject To An External Light Source To Cause The Prodrug To Release The Active Ingredient. This Invention Also Provides A Composition For The Treatment Of Glaucoma, Comprising A Compound Containing A Lithium Ion-Chelated In A Crown Ether- Or Aza-Crown Ether-Containing Chromene Or Diazene Derivative And A Pharmaceutically Acceptable Carrier.
 
patents.description.assigneeUniv Hong Kong [Cn]
 
patents.description.ccUS
 
patents.description.countryUnited States of America
 
patents.description.kindB2
 
dc.description.naturepublished_or_final_version
 
patents.identifier.applicationUS 11/313513
 
dc.identifier.citationUS Patent 7468434. Washington, DC: US Patent and Trademark Office (USPTO), 2008 [How to Cite?]
 
patents.identifier.grantedUS 7468434
 
patents.identifier.hkutechidChm-2004-00168
 
patents.identifier.publicationUS 20070298127
 
dc.identifier.urihttp://hdl.handle.net/10722/142068
 
patents.relation.familyCN 101115489 (A) 2008-01-30
 
patents.relation.familyDE 112005003183 (T5) 2007-11-08
 
patents.relation.familyGB 2437456 (A) 2007-10-24
 
patents.relation.familyJP 2008524268 (A) 2008-07-10
 
patents.relation.familyUS 2007298127 (A1) 2007-12-27
 
patents.relation.familyUS 7468434 (B2) 2008-12-23
 
patents.relation.familyWO 2006066511 (A1) 2006-06-29
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents
 
dc.titleDiazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use
 
dc.typePatent
 
patents.typePatent_granted
 
<?xml encoding="utf-8" version="1.0"?>
<item><date.accessioned>2011-10-19T06:25:03Z</date.accessioned>
<date.available>2011-10-19T06:25:03Z</date.available>
<date.issued>2008</date.issued>
<identifier.citation>US Patent 7468434. Washington, DC: US Patent and Trademark Office (USPTO), 2008</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/142068</identifier.uri>
<description.abstract>This Invention Provides A Method For Treating An Eye Disease In A Patient Comprising: Providing A Photosensitive Prodrug That Releases Upon Exposure To Light An Active Ingredient To Treat The Eye Disease; Administering The Prodrug In A Pharmaceutically Accepted Vehicle To The Subject, And Exposing The Eye Of The Subject To An External Light Source To Cause The Prodrug To Release The Active Ingredient. This Invention Also Provides A Composition For The Treatment Of Glaucoma, Comprising A Compound Containing A Lithium Ion-Chelated In A Crown Ether- Or Aza-Crown Ether-Containing Chromene Or Diazene Derivative And A Pharmaceutically Acceptable Carrier.</description.abstract>
<rights>Creative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents</rights>
<title>Diazene-Bridge Crown Ether Lithium Compounds And Methods For Their Use</title>
<type>Patent</type>
<description.nature>published_or_final_version</description.nature>
<contributor.inventor>Vanhoutte, Paul Michel Geo</contributor.inventor>
<contributor.inventor>Che, Chi Ming</contributor.inventor>
<contributor.inventor>So, Kwok Fai</contributor.inventor>
<contributor.inventor>Sham, Hiu Tung Iona</contributor.inventor>
<patents.identifier.application>US 11/313513</patents.identifier.application>
<patents.identifier.granted>US 7468434</patents.identifier.granted>
<patents.description.assignee>Univ Hong Kong [Cn]</patents.description.assignee>
<patents.description.country>United States of America</patents.description.country>
<patents.date.publication>2007-12-27</patents.date.publication>
<patents.date.granted>2008-12-23</patents.date.granted>
<patents.identifier.hkutechid>Chm-2004-00168</patents.identifier.hkutechid>
<patents.date.application>2005-12-21</patents.date.application>
<patents.date.priority>2005-12-21 US 11/313513</patents.date.priority>
<patents.date.priority>2004-12-22 US 11/638100P</patents.date.priority>
<patents.description.cc>US</patents.description.cc>
<patents.identifier.publication>US 20070298127</patents.identifier.publication>
<patents.relation.family>CN 101115489 (A)  2008-01-30</patents.relation.family>
<patents.relation.family>DE 112005003183 (T5)  2007-11-08</patents.relation.family>
<patents.relation.family>GB 2437456 (A)  2007-10-24</patents.relation.family>
<patents.relation.family>JP 2008524268 (A)  2008-07-10</patents.relation.family>
<patents.relation.family>US 2007298127 (A1)  2007-12-27</patents.relation.family>
<patents.relation.family>US 7468434 (B2)  2008-12-23</patents.relation.family>
<patents.relation.family>WO 2006066511 (A1)  2006-06-29</patents.relation.family>
<patents.description.kind>B2</patents.description.kind>
<patents.type>Patent_granted</patents.type>
<bitstream.url>http://hub.hku.hk/bitstream/10722/142068/1/Patent.pdf</bitstream.url>
</item>